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The EGFR demonstrates linear signal
transmission†
Diego A. Oyarzu´n,a Jo L. Bramhall,b Fernando Lo´pez-Caamal,c
Frances M. Richards,d Duncan I. Jodrellbd and Ben-Fillippo Krippendorff‡*bd
Cells sense information encoded in extracellular ligand concentrations and process it using intracellular
signalling cascades. Using mathematical modelling and high-throughput imaging of individual cells, we
studied how a transient extracellular growth factor signal is sensed by the epidermal growth factor receptor
system, processed by downstream signalling, and transmitted to the nucleus. We found that transient
epidermal growth factor signals are linearly translated into an activated epidermal growth factor receptor
integrated over time. This allows us to generate a simplified model of receptor signaling where the
receptor acts as a perfect sensor of extracellular information, while the nonlinear input–output relationship
of EGF-EGFR triggered signalling is a consequence of the downstream MAPK cascade alone.
Insight, innovation, integration
We derived an analytical formula from nonlinear models of receptor signalling that have been used to model the signalling of the epidermal growth
factor receptor (EGFR). The formula predicted that the cumulative EGFR signalling is linearly dependent on the ligand concentration outside the cell.
Quantitative imaging of HeLa cells suggests that the cumulative EGFR signalling indeed depends linearly on the EGF concentration. Our mathematical
approach therefore allows a simplified view on complex networks of receptor dynamics and describes the EGFR as a linear sensor of extracellular information
encoded in ligand concentrations.
1 Introduction
Growth factors control a number of cellular responses such
as proliferation, differentiation, apoptosis and angiogenesis.
Despite our comprehensive knowledge of some of the processes
involved in growth factor sensing and signalling, we still lack a
quantitative grasp of how they modulate the transmission of
growth stimuli to the nucleus. One of the obstacles is the presence
of regulatory feedback loops acting on both surface receptors and
downstream signalling, which obscure the input–output relation-
ship between the ligand stimulus and the transmitted signal.1
Moreover, growth factor signalling is a transient phenomenon
because cells bind, internalize, and degrade ligands from
the extracellular space. This causes receptor activation to
weaken over the course of experiments, and thus extensive
time course data are required to fully dissect the roles of
individual processes.
The number of surface receptors available for binding is
determined by receptor-related processes such as turnover,
internalization, recycling and degradation.2 As a consequence,
cell surface receptors such as the epidermal growth factor
receptor (EGFR) are increasingly being regarded as important
regulators of downstream signalling.1,3 The number of EGFR
molecules at the cell surface is regulated by a number of dynamical
processes (Fig. 1A): newly produced receptors are translocated
to the cell membrane, while receptors at the cell surface are
constantly exchanged with intracellular endosomal compart-
ments via clathrin-mediated endocytosis.4 Further, internalized
receptors can be recycled to the cell surface from early endosomes
and late recycling compartments by fusing with the plasma
membrane.5 Endosomes that are not recycled eventually fuse with
lysosomes which lead to proteolysis of the attached receptors and
the bound ligands.6 The level of free EGFRs at the surface is
therefore determined by the relative contributions of the individual
trafficking and degradation processes.
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The ligands in the extracellular space also influence the fate
of receptors at the cell membrane. Binding of ligands to the
EGFR, for example, induces dimerization and autophosphor-
ylation of intracellular residues.7 These phosphorylations are
responsible for the activation of different downstream signal-
ling cascades, most prominently the mitogen-activated protein
kinase (MAPK) cascade, composed of Ras-Raf-Mek-Erk, and the
PI3K-Akt cascade.8 At the same time, ligand binding perturbs
the balance of the individual receptor trafficking processes by
increasing the internalization rate of the EGFR.9,10 Via this
mechanism, receptor activation can potentially exert a negative
feedback effect by increasing internalisation, and eventually
degradation, of receptors and ligands in lysosomes.1,11,12
A number of mathematical models for the EGFR system have
shed new light on the design principles underpinning growth
factor signalling. One of the first examples was the steady state
model of EGFR activation and trafficking by Wiley et al.13 EGFR
models have also proven useful to describe other receptor systems
subject to the same processes (binding, internalization and
recycling), but with parameter values that describe particular
instances of a core network model.14 Increasingly detailed models
have been recently built to capture the mechanistic processes that
control the input–output relationship of the EGFR system.15
Here we report our studies on the relationship between the
extracellular ligand concentration and processes influencing
EGFR signaling, such as ligand binding and receptor trafficking.
We describe a previously unreported feature of EGFR signalling: its
ability to linearly transmit extracellular ligand cues into cytoplasmic
receptor activation. Using a combination of mathematical
modelling, analysis and high-throughput imaging, we present
evidence suggesting that receptor trafficking produces a linear
input–output relationship between the initial ligand concen-
tration and the cumulative receptor phosphorylation. The cyto-
plasmic signal in turn acts as an input to subsequent signalling
cascades that cause signal saturation.
2 Materials and methods
Cell culture
The human cervical carcinoma HeLa cells were obtained from the
CRUK Cambridge Institute and were authenticated by STR geno-
typing as well as tested negative for mycoplasma. These cells were
maintained with Dulbecco’s Modified Eagle Medium (DMEM) (Life
Technologies Ltd, Paisley, UK) supplemented with 10% Fetal
Calf Serum (FCS) (Life Technologies Ltd, Paisley, UK) at 37 1C in
a humidified atmosphere of 5% CO2 in atmospheric O2 levels.
Immunofluorescence
Immunofluorescence was performed in ibidi 96-well plates (ibidi
GmbH, Germany); cells were incubated at 37 1C for 24 h. After
24 h, the medium was replaced with medium containing no
serum and incubated for a further 16 h at 37 1C. The cells were
stimulated with 0, 6.25, 12.5, 25 and 50 ng ml1 EGF (#01-101,
Millipore, USA) at various time points, fixed with 4% paraform-
aldehyde in PBS and blocked with PBS/1% BSA (w/v)/0.1%
saponin (w/v) (PBS/B/S) and 5% goat serum (v/v) (GS) for 1 h.
The cells were incubated for 16 h at 4 1C with pEGFR (rabbit
polyclonal anti-pEGFR Tyr1068, #3777 Ab, 1 : 600; Cell Signalling
Technologies) and ppErk1/2 (mouse polyclonal anti-ppErk1/2
Fig. 1 Linear signal transmission in a model for epidermal growth factor receptor (EGFR) binding, turnover and trafficking. (A) EGF-induced signalling
comprises ligand sensing by the EGFR on the cell surface, transmission of the sensed signal via the MAPK cascade, and nuclear import of active ERK. The
extracellular EGF binds to free EGFR, triggering its dimerization and subsequent phosphorylation (pEGFR). Active receptors trigger the activation of the
MAPK cascade and also get internalized by endosomes (pEGFRi). The endosomes are either degraded or recycled back to the cell surface. The MAPK
cascade results in ppErk in the cytoplasm, which is finally imported into the nucleus to induce transcriptional changes. Eqn (1) is an ODE model of
receptor binding, turnover and trafficking; the parameters are described in Table S1 in the ESI.† (B) Here we investigate the input–output relationship
between a certain bolus extracellular stimulus (EGF concentration) and the resulting EGFR phosphorylation integrated over time (area under the
activation curve). (C) The model predicts a linear input–output relationship between the ligand concentration and integrated receptor phosphorylation.
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T185, Y187 T202 Y204, #ab50011 Ab, 1 : 500; Abcam). The plates
were washed with PBS/B/S + 1% GS five times and incubated with
secondary antibodies, antimouse IgG Alexa Fluor 488 (44085 Ab,
1 : 1000; Cell Signalling Technologies), antirabbit IgG Alexa Fluor
647 (44145 Ab, 1 : 1000; Cell Signalling Technologies) and DAPI
(Invitrogen) for 1 h in the dark at room temperature. The plates
were washed with PBS/B/S + 1% GS five times and stored in PBS at
4 1C in the dark until analysis.
High-throughput imaging
Quantitative imaging was performed by acquiring pictures of
each well of the 96-well plate using the iCys Research Imaging
Cytometer (CompuCyte, MA, USA) using 40magnification and
405 nm, 488 nm, and 633 nm lasers. This microscope is purpose-
built for the quantification of fluorescent signals in cells and is
widely used for Laser Scanning Cytometry. Analysis of the field
images is performed using the Columbus software (version 2.3,
PerkinElmer) andMatlab (version 7.14, Mathworks). In each plate,
two wells for each timepoint and treatment were measured. The
data were then normalised in Prism (version 5, Graphpad) on
each plate by defining the signal seen in the unstimulated wells as
zero and the highest signal measured on the plate as one. Detailed
information about the quantification of the field images and the
data analysis pipeline can be found in Section S2 of the ESI.†
Mathematical modelling and analysis
The details of the mathematical methods can be found in the
ESI.† Extensions of our method to compute the time-integrals of
species concentrations in nonlinear reaction–diffusion models
can be found in ref. 16.
3 Results
Exact computation of the integrated response in signalling
networks
To investigate the relationship between EGFR trafficking and
receptor activation, we first built an Ordinary Differential
Equation (ODE) model for ligand binding, receptor trafficking,
and turnover. The model comprises the receptor processes in
Fig. 1A and describes the dynamic response of the ligand, free
receptors, active receptors and endosomes:
dL
dt
¼ f ðtÞ  konR  Lþ koffC þ krCint;
dR
dt
¼ ks  ktR konR  Lþ koffC þ krCint;
dC
dt
¼ konR  L koffC  keC;
dCint
dt
¼ keC  krCint  kdeCint:
(1)
Here L is the concentration of the EGF ligand supplied to the
medium at a rate f (t), R is the concentration of free receptors
(EGFR), C is the concentration of phosphorylated receptors
(pEGFR), and Cint is the concentration of endosomes (pEGFRi).
The parameters of the model are described in Table S1 in the ESI.†
This model has been widely used to describe the EGFR and other
receptor tyrosine kinase systems such as HER2,14,16–19 as well as
cytokine receptors such as the erythropoietin receptor (EpoR) and
the interleukin-3 receptor.14,20
We focused on the relationship between the ligand concen-
tration (dose) and the area under the receptor activation curve (see
Fig. 1B). This time-integral represents the cumulative activation of
the receptor over time and depends on the duration and peak of
activation. The area under the activation curve is a good measure
of a transient response and has proven useful to study signaling
cascades,21,22 reaction–diffusion systems,23 cell surface receptors,20
and was also found to link ERK activation with DNA synthesis.24
To study the input–output relationship of cellular signaling
models, simulations are typically used to obtain sensitivities of
outputs on the different model components. Conclusions drawn
from simulation-based studies, however, can depend strongly on
the specific parameter values used in the simulations. Moreover,
model parameters are typically subject to high uncertainty due to
the limited quantitative knowledge of the reaction kinetics and
the limited datasets available for parameter estimation.
We here present an analytic approach to quantify the input–
output relationship of cellular signaling models. To derive conclu-
sions that are independent of the parameter values, we sought to
analytically solve the time-integrals of the activated receptors as a
function of the parameters. Signaling networks, however, display
highly nonlinear dynamics and thus exact model solutions are hard
(if not impossible) to obtain. We developed a mathematical
approach to obtain exact formulae for the integrated response of
signalling networks under external inputs.
We considered a signalling network with m reactions and
n chemical species
Xn
i¼1
aijsi  !
vj Xn
i¼1
bijsi; j ¼ 1; 2; . . . ;m;
for j = 1, 2,. . ., m. The variables si represent species concentra-
tions, whereas aij and bij are the stoichiometric coefficients of
species si in reaction vj. To account for the interaction between
the network and its environment, the species may be supplied
to or consumed from the network at rate ui. An ODE model for
the network reads
ds
dt
¼ NvðsÞ þDu;
where s is the vector of species concentrations, v is the vector of
reaction rates, and u is the vector of external stimuli. The
stoichiometric matrix N has entries Nij = bij  aij; species si is
consumed or produced in reaction vj whenever Nijo 0 or Nij4 0.
We modelled the effect of the stimuli with the matrix D, which
determines which species are affected by the stimulus uj (for
example, to model an influx uj of species si, we choose the
jth column of D to have 1 in its ith entry and zeros elsewhere).
We consider stimuli signals of the form u(t) = %u + d(t), with %u
being a constant stimulus and d(t) being a transient signal that
vanishes to zero after sufficiently long time. After the transient
stimuli have vanished, we assume that the network reaches a
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unique and globally stable steady state %s that matches the pre-
stimulus steady state concentrations.
We obtained conditions on the network structure and reaction
kinetics under which the integrated response of some of the
species can be exactly computed from the formula:
ð1
0
si  sið Þdt ¼ f ðpÞ ~s0 þ uTð Þ; (2)
where %si is the steady state concentration of si, f ( p) is a nonlinear
function of the model parameters (including for example, the
stoichiometry and kinetic parameters), s˜0 = si(0)  %si is the
initial deviation of si from its steady state concentration, and
uT ¼
Ð1
0 ddt is the net concentration of species supplied to the
network by the transient signal d(t). The formula in eqn (2)
holds under conditions that depend on the stoichiometry and
nonlinear kinetics, and describes the integrated response of
si in terms of the kinetic parameters, initial concentrations
and external stimuli. The derivation of the network conditions
can be found in Section S1.1 and S1.2 of the ESI;† further
extensions and interpretations of these conditions for spatio-
temporal models can be found in ref. 16.
The EGFR displays linear signal transmission
Using our approach in the model for EGFR binding, turnover
and trafficking (Fig. 1A), we found a simple linear input–output
formula for the integrated receptor activation A:
A ¼ 1
ke
1þ ke þ kr
kde
 
Ltotal; (3)
where Ltotal is the total concentration of the ligand supplied to
the extracellular medium. The linear relationship is illustrated
in Fig. 1B and C and its derivation can be found in Section S1.3
in the ESI.† For the consideredmodel, the formula in eqn (3) is an
exact description of the cumulative concentration of membrane-
bound and internalised active receptors (pEGFR and pEGFRi in
Fig. 1A) following a ligand stimulus; given the model-specific
parameter values, the formula can be used to quantitatively
predict the magnitude of receptor activation. The expression in
Fig. 2 Transient activation of the EGFR after stimulation of HeLa cells with different concentrations of EGF. (A) Serum starved HeLa cells were stimulated
with 50 ng ml1 EGF for different times; the chosen concentrations are within the range where EGFR phosphorylation was detectable via western blot,
see ESI.† The cells were stained for DNA (DAPI) and pEGFR (Y1068) for imaging. Individual cells were identified based on DAPI staining and segmentation
of the cytoplasmic staining as described in the Material and methods section. The EGF concentrations for stimulation were determined by western
blotting (Fig. S4, ESI†). (B) Cytoplasmic and membrane staining was quantified for ca. 1500 individual cells per well. For each 96-well plate the data were
normalised by dividing by the highest value per well observed over all timepoints. Data represent the mean of all quantified cells, while error bars
represent the standard error between three biological replicates. (C) The measured pEGFR signal was integrated over time for the indicated
concentrations of the EGF. Integrated activation was normalised to the highest value observed for the different ligand concentrations on the plate.
Error bars represent the standard error between three biological replicates. The dashed line is a linear fit of the data.
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(3) suggests that not all the processes affect the cumulative
activation. In particular, receptor turnover (determined by kt
and ks) as well as ligand binding (kon and koff) cancel out and do
not affect the activation integrated over time. The formula for
A therefore predicts that, despite the nonlinearities introduced
by the limited amount of receptors available for binding, the
integrated receptor activation scales linearly with the ligand
concentration.
We then asked whether the predicted linearity is a consequence
of the specific binding kinetics assumed in the model (described as
a bimolecular mass action process), and consequently computed
the integrated activation for a generic family of binding kinetics.
We found that the linear signal transmission seems to be inde-
pendent of the binding mechanism (see Section S1.4 in the ESI†)
and furthermore, it should appear even when assuming satur-
able or cooperative binding.
Our result suggests that cumulative activation of EGFR depends
on the trafficking processes, that is, on the interplay between
receptor recycling, internalization and breakdown. Receptor traffick-
ing therefore seems to be the key process enabling a broad dynamic
range in EGFR signal transmission. Since this principle emerges
independently of specific parameter values, it also suggests that it
could be a robust property conserved across the family of receptors
subject to trafficking, binding and turnover processes.
To experimentally test our theoretical prediction, we measured
the temporal response of EGF-triggered phosphorylation of the
EGFR in HeLa cells with high-throughput quantitative immuno-
fluorescence imaging. We first determined the range of EGFR
Fig. 3 Transient activation of ppErk1/2 after stimulation of HeLa cells with different concentrations of EGF. (A) In addition to EGFR quantification as
shown in Fig. 2, ppErk1/2 (T185/Y187, T202/Y204) was quantified to investigate how the receptor signal is changed by downstream signalling. The
measurements were obtained and normalized as described in Fig. 2. (B) To distinguish between cytoplasmic and nuclear levels of ppErk the nuclear area
was contoured by DAPI staining as described in the Material and methods section. The nuclear ppErk signals were normalized by dividing by the highest
value for the cytoplasmic area to allow for a comparison of cytoplasmic and nuclear values.
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concentrations that resulted in measurable EGFR phosphorylation
(details in the ESI†). For the batch of EGF used, EGFR phosphoryla-
tion was measured for concentrations above 10 ng ml1 using
quantitative western blotting. Next, we serum starved HeLa cells to
eliminate all growth factor mediated EGFR phosphorylation and
then stimulated the cells with 6.25 to 50 ng ml1 EGF.
The imaging approach was used to determine the signal in
different compartments of the cell. Further, single-cell imaging
allows us to derive a mean value of thousands of individual
measurements. We scanned 96-well plates using a laser cytometer
and segmented individual cells from the collected images (Fig. 2A
and details in Materials and methods). We then quantified in
each cell the level of EGFR phosphorylation at Y1068, which is
crucial for downstream signalling and activation of the MAPK
cascade resulting in Erk1/2 activation.9,25
The mean EGFR phosphorylation peaked at around 15 min
after EGF stimulation (Fig. 2B), followed by a slow reduction of
the pEGFR signal corresponding to the internalization and
degradation of the activated receptor after around 5–20 min.26
At later timepoints localised intracellular staining close to the
nucleus was apparent, most likely representing trafficking of the
EGFR to the endoplasmic reticulum. We integrated the mean
phosphorylation level of all measured cells over the timescale of
the experiment (0–100 minutes). In agreement with our theore-
tical predictions, the integrated response of pEGFR was found to
be proportional to the initial EGF concentrations (Fig. 2C),
confirming that the EGFR linearly translates the extracellular
EGF into an integrated response of receptor phosphorylation.
We suggest that the linear signal transmission may be a
consequence of a negative feedback exerted by receptor trafficking.
Processes such as receptor endocytosis, recycling and degradation
processes determine receptor activation integrated over time and
hence limit receptor signaling. As a consequence, the model
suggests that in cancer cells mutations that reduce receptor
internalization and degradation could be especially beneficial
to maximize stimulation from a limited supply of growth factors.
This could be another aspect of the important role of mutations
that modify receptor trafficking in cancer.27–30
The MAPK cascade limits the dynamic range of signal
transmission
Next we investigated how the linear signal of activated EGFR is
transmitted into the cytoplasm and nucleus. In addition to
pEGFR, we measured activated Erk1/2 in the cytoplasm and the
nucleus (Fig. 3A) using an additional antibody specific to
double phosphorylated Erk1/2. The high-throughput imaging
approach hence allowed us to determine pEGFR and ppERK1/2
levels for individual cells.
We found that the time profile of Erk activation follows a
similar shape to that of receptor activation, but reaches its peak
earlier at around 8–10 min and drops sharper afterwards
(Fig. 3B). This quick response of Erk1/2 upon upstream receptor
activation has been previously ascribed to the ultrasensitive
behaviour arising from double phosphorylation of ERK by MEK
and positive feedback.31–34
However, in contrast to the linear response of the integrated
pEGFR signal (Fig. 2C), it can be observed from the time profiles for
25 and 50 ng ml1 the EGF triggers a nearly identical ppErk1/2
response (Fig. 3B). This means that the ppErk1/2 response saturates
for high ligand concentrations, and hence suggests that the MAPK
cascade may limit the dynamic range of signal transmission.
Using DAPI staining to contour the nuclear regions also
allowed us to determine the localization of ppErk1/2 inside the
cell (Fig. 3B). We found that the nuclear level of ppErk1/2
showed a similar time course as the cytoplasmic levels, but
the staining intensity of ppErk1/2 was higher in the nucleus
Fig. 4 Modular input–output description EGF signalling. The blocks represent subsystems and the arrows represent the signals interconnecting them.
To determine the input–output relationship the integrals of the measured proteins are plotted against each other. Data points are individual biological
replicates normalized to the highest value observed on one plate. Dashed lines are linear fits and the curves are Michaelis–Menten fits of the data.
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than in the cytoplasm. This apparent amplification of the
signal in the nucleus however could potentially be due to the
bright field imaging, because cells are flattest at the cyto-
plasmic region and thus the cytoplasmic signal is integrated
over a smaller volume than the nuclear signal.
Finally, to understand how each individual signalling stage
contributes to signal transmission from the extracellular space to
the nucleus, we integrated the ppErk1/2 response over time and
deconvolved the EGF signalling data into three subsystems (Fig. 4)
the receptor subsystem, the MAPK cascade, and the nuclear import
of active Erk1/2. Both the receptor and nuclear import display linear
signal transmission, whereas the MAPK cascade introduces a satur-
able response. The input–output relationship of the complete system
therefore displays saturation, which limits the cellular sensitivity to
stronger EGF stimuli. This suggests that the nonlinear relationship
between the EGF concentration and cumulative nuclear ppErk1/2
results only from the dynamics of the MAPK cascade.
4 Conclusions
The link between growth factors and cellular responses depends
on how extracellular signals are sensed and transmitted from the
cell surface to the nucleus. In this article we used a modular
approach to study how an EGF signal is transmitted by the EGFR
system, the downstreamMAPK signalling cascade, and the nuclear
import of ppERK1/2. Our main finding is that the receptor system
displays a linear input–output relationship between the ligand
concentration and the cumulative receptor activation over time.
We therefore conclude that the receptor system might act like a
linear sensor, translating extracellular information proportionally
into an intracellular signal.
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